Revista Angiología 00619 / http://dx.doi.org/10.20960/angiologia.00619

Resumen| PDF

Artículos Especiales

Documento de consenso de la Sociedad Española de Obstetricia y Ginecologia (SEGO) y el Comité Español Interdisciplinario para la Prevención Vascular (CEIPV). Ventana de oportunidad: prevención del riesgo vascular en la mujer. Resultados adversos del embar

María Goya, Marta Miserachs, Anna Suy Franch, Jorge Burgos, María de la Calle, Carlos Brotons, María del Mar Castellanos, Olga Cortés, Ángel Díaz Rodríguez, Roberto Elosúa, María del Mar Freijo, María González Fondado, Manuel Gorostidi, María Grau, Antonio M. Hernández Martínez, Carlos Lahoz, Nuria Muñoz-Rivas, Vicente Pallarés-Carratalá, Juan Pedro-Botet, Enrique Rodilla, Miguel Ángel Royo-Bordonada, Rafael Santamaría, Mónica Torres Fonseca, Alina Velescu, Alberto Zamora, Pedro Armario

Prepublicado: 2024-02-15

Publicado: 2024-04-10

VOLUMEN 76, NÚM. 2, marzo-abril (2024), PAG. 97-98

Logo Descargas Número de descargas: 339 Logo Visitas Número de visitas: 332 Citas Citas: 0

Compártelo:

Este documento resume la evidencia que existe entre los resultados adversos del embarazo (RAE) y el riesgo que tiene una persona gestante de desarrollar factores de riesgo vascular (RV) que pueden terminar provocando enfermedad vascular (EV) futura. Asimismo, este documento destaca la importancia de saber reconocer los RAE cuando se evalúa el RV en mujeres. Un antecedente de RAE es un indicador suficiente para hacer una prevención primaria de EV. De hecho, adoptar una dieta saludable y aumentar la actividad física entre las mujeres con RAE, de inicio en el embarazo o en el posparto y manteniéndolas a lo largo de la vida, son intervenciones importantes que permiten disminuir el RV. Por otro lado, la lactancia materna también puede disminuir el RV posterior de la mujer, incluyendo menos riesgo de mortalidad. Estudios futuros que evalúen el uso del ácido acetilsalicílico, las estatinas y la metformina, entre otros, en las mujeres con antecedentes de RAE podrían reforzar las recomendaciones sobre el uso de la farmacoterapia en la prevención primaria de la EV entre estas pacientes. Existen diferentes opciones dentro de los sistemas de salud para mejorar la transición de la atención de las mujeres con RAE entre los diferentes profesionales e implementar estrategias para reducir su RV a largo plazo. Una posible estrategia podría ser la incorporación del concepto del cuarto trimestre en las recomendaciones clínicas y las políticas de atención de la salud.

Palabras Clave: Riesgo vascular. Embarazo. Posparto. Prevención de riesgo.

Descargar PDF

Bibliografía

Zeng Z, Liu F, Li S. Metabolic Adaptations in Preg- nancy: A Review. Ann Nutr Metab. 2017;70:59-65.
DOI: 10.1159/000459633

Gillespie SL, Porter K, Christian LM. Adaptation of the inflammatory immune response across pregnancy and postpartum in Black and White women. J Reprod Immunol. 2016;114:27-31.
DOI: 10.1016/j.jri.2016.02.001

Lane-Cordova AD, Khan SS, Grobman WA, Green- land P, Shah SJ. Long-Term Cardiovascular Risks Asso- ciated With Adverse Pregnancy Outcomes. J Am Coll Cardiol. 2019;73:2106-2116.
DOI: 10.1016/j.jacc.2018.12.092

ACOG Practice Bulletin. Gestational Hyperten- sion and Preeclampsia. Obstetrics & Gynecology. 2020;135:e237-260.
DOI: 10.1097/AOG.0000000000003891

Wallis AB, Sastlas AF, Hsia J, Atrash HK. Secular Trends in the Rates of Preeclampsia, Eclampsia, and Gestational Hypertension, United States, 1987-2004. Am J Hypertens. 2008;21:521-526.
DOI: 10.1038/ajh.2008.20

Centers for Disease Control (CDC). Gestational Dia- betes. 2020 (consultado 11 de junio 2023).

Ananth C V., Keyes KM, Hamilton A, Gissler M, Wu C, Liu S et al. An International Contrast of Rates of Pla- cental Abruption: An Age-Period-Cohort Analysis. PLoS One. 2015;10:e0125246.
DOI: 10.1371/journal.pone.0125246

Osterman MJK, Hamilton BE, Martin JA, Driscoll AK, Valenzuela CP. Births: Final Data for 2021. Natl Vi- tal Stat Rep. 2023;72:1-53.

Aris IM, Kleinman KP, Belfort MB, Kaimal A, Oken

E. A 2017 US Reference for Singleton Birth Weight Per- centiles Using Obstetric Estimates of Gestation. Pedia- trics. 2019;144:e2019076
DOI: 10.1542/peds.2019-0076

Doty MS, Chen HY, Sibai BM, Chauhan SP. Maternal and Neonatal Morbidity Associated With Early Term De- livery of Large-for-Gestational-Age But Nonmacrosomic Neonates. Obstetrics & Gynecology. 2019;133:1160-1166.
DOI: 10.1097/AOG.0000000000003285

Grandi SM, Filion KB, Yoon S, Ayele HT, Doyle CM, Hutcheon JA et al. Cardiovascular Disease-Related Mor- bidity and Mortality in Women With a History of Preg- nancy Complications. Circulation. 2019;139:1069-1079.
DOI: 10.1161/CIRCULATIONAHA.118.036748

Parikh NI, Gonzalez JM, Anderson CAM, Judd SE, Rexrode KM, Hlatky MA et al. Adverse Pregnancy Out- comes and Cardiovascular Disease Risk: Unique Oppor- tunities for Cardiovascular Disease Prevention in Wo- men: A Scientific Statement From the American Heart Association. Circulation. 2021;143(18).
DOI: 10.1161/CIR.0000000000000961

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M et al. 2021 ESC Guidelines on car- diovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227-3337.
DOI: 10.1093/eurheartj/ehab484

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS et al. 2018 AHA/ACC/AACVPR/ AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guide- lines. Circulation. 2019;139(25).
DOI: 10.1161/CIR.0000000000000698

Markovitz AR, Stuart JJ, Horn J, Williams PL, Rimm EB, Missmer SA et al. Does pregnancy complication history improve cardiovascular disease risk prediction? Findings from the HUNT study in Norway. Eur Heart J. 2019;40:1113-1120.
DOI: 10.1093/eurheartj/ehy863

Riise HKR, Sulo G, Tell GS, Igland J, Egeland G, Nygard O et al. Hypertensive pregnancy disorders in- crease the risk of maternal cardiovascular disease after adjustment for cardiovascular risk factors. Int J Cardiol. 2019;282:81-87.
DOI: 10.1016/j.ijcard.2019.01.097

Riise HKR, Sulo G, Tell GS, Igland J, Nygård O, Iver- sen A et al. Association Between Gestational Hyperten- sion and Risk of Cardiovascular Disease Among 617 589 Norwegian Women. J Am Heart Assoc. 2018;7;e008337
DOI: 10.1161/JAHA.117.008337

Theilen LH, Meeks H, Fraser A, Esplin MS, Smith KR, Varner MW. Long-term mortality risk and life expec- tancy following recurrent hypertensive disease of preg- nancy. Am J Obstet Gynecol. 2018;219:107.e1-107.e6.
DOI: 10.1016/j.ajog.2018.04.002

Stuart JJ, Tanz LJ, Cook NR, Spiegelman D, Missmer SA, Rimm EB et al. Hypertensive Disorders of Pregnancy and 10-Year Cardiovascular Risk Prediction. J Am Coll Cardiol. 2018;72:1252-1263.
DOI: 10.1016/j.jacc.2018.05.077

Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in wo- men: a systematic review and meta-analysis. Diabetolo- gia. 2019;62:905-914.
DOI: 10.1007/s00125-019-4840-2

Turi V, Iurciuc S, Cretu OM, Tit DM, Bungau S, Apostol A et al. Arterial function in hypertensive preg- nant women. Is arterial stiffness a marker for the outco- mes in pregnancy? Life Sci. 2021, 264, 118723.

Tanz LJ, Stuart JJ, Williams PL, Missmer SA, Rimm EB, James-Todd TM et al. Preterm Delivery and Mater- nal Cardiovascular Disease Risk Factors: The Nurses’ Health Study II. J Womens Health. 2019;28:677-685.
DOI: 10.1089/jwh.2018.7150

Arnold L, Hoy W, Wang Z. Low birthweight in- creases risk for cardiovascular disease hospitalisa- tions in a remote Indigenous Australian community-a prospective cohort study. Aust N Z J Public Health. 2016r;40:S102-106.
DOI: 10.1111/1753-6405.12426

Morken NH, Halland F, DeRoo L, Wilcox A, Sk- jaerven R. Offspring birthweight by gestational age and parental cardiovascular mortality: a population-based cohort study. BJOG. 2018;123:336-341.
DOI: 10.1111/1471-0528.14522

Hall PS, Nah G, Vittinghoff E, Parker DR, Manson JE, Howard BV et al. Relation of Pregnancy Loss to Risk of Cardiovascular Disease in Parous Postmenopausal Women (From the Women’s Health Initiative). Am J Car- diol. 2019;123:1620-1625.
DOI: 10.1016/j.amjcard.2019.02.012

Peters SA, Woodward M. Women’s reproductive factors and incident cardiovascular disease in the UK Biobank. Heart. 2018;104:1069-1075.
DOI: 10.1136/heartjnl-2017-312289

Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28(1):1-19.
DOI: 10.1007/s10654-013-9762-6

Hermes W, Ket JCF, van Pampus MG, Franx A, Vee- nendaal MVE, Kolster C et al. Biochemical Cardiovas-

cular Risk Factors After Hypertensive Pregnancy Disor- ders. Obstet Gynecol Surv. 2012;67:792-808.
DOI: 10.1097/OGX.0b013e31827682fc

Vounzoulaki E, Khunti K, Abner SC, Tan BK, Da- vies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ. 2020;m1361.
DOI: 10.1136/bmj.m1361

Rayanagoudar G, Hashi AA, Zamora J, Khan KS, Hitman GA, Thangaratinam S. Quantification of the type 2 diabetes risk in women with gestational diabetes: a systematic review and meta-analysis of 95,750 women. Diabetologia. 2016;59:1403-1411.
DOI: 10.1007/s00125-016-3927-2

Parikh NI, Norberg M, Ingelsson E, Cnattingius S, Vasan RS, Domellöf M et al. Association of Pregnancy Complications and Characteristics with Future Risk of Elevated Blood Pressure. Hypertension. 2017;69:475-483.
DOI: 10.1161/HYPERTENSIONAHA.116.08121

Fraser A, Nelson SM, Macdonald-Wallis C, Cherry L, Butler E, Sattar N et al. Associations of Pregnancy Complications with Calculated Cardiovascular Disease Risk and Cardiovascular Risk Factors in Middle Age. Cir- culation. 2012;125:1367-1380.
DOI: 10.1161/CIRCULATIONAHA.111.044784

Sociedad Española de Diabetes (SED) Sociedad Es- pañola de Ginecología y Obstetricia (SEGO). Asistencia a la gestante con diabetes. Guía de práctica clínica ac- tualizada. Av Diabetol. 2015;31(2):45-49.
DOI: 10.1016/j.avdiab.2014.12.001

Haas DM, Parker CB, Marsh DJ, Grobman WA, Ehrenthal DB, Greenland P et al. Association of Adver- se Pregnancy Outcomes with Hypertension 2 to 7 Years Postpartum. J Am Heart Assoc. 2019;8(19).
DOI: 10.1161/JAHA.119.013092

Cortés YI, Catov JM, Brooks M, Harlow SD, Isasi CR, Jackson EA et al. History of Adverse Pregnancy Out- comes, Blood Pressure, and Subclinical Vascular Mea- sures in Late Midlife: SWAN (Study of Women’s Health Across the Nation). J Am Heart Assoc. 2018;7(1).
DOI: 10.1161/JAHA.117.007138

Catov JM, Dodge R, Yamal JM, Roberts JM, Piller LB, Ness RB. Prior Preterm or Small-for-Gestational-Age Birth Related to Maternal Metabolic Syndrome. Obste- trics & Gynecology. 2011;117:225-232.
DOI: 10.1097/AOG.0b013e3182075626

Horn J, Tanz L, Stuart J, Markovitz A, Skurnik G, Rimm E et al. Early or late pregnancy loss and development of clinical cardiovascular disease risk factors: a prospective cohort study. BJOG. 2019;126:33-42.
DOI: 10.1111/1471-0528.15452

Parikh NI, Jeppson RP, Berger JS, Eaton CB, Kroenke CH, LeBlanc ES et al. Reproductive Risk Factors and Co- ronary Heart Disease in the Women’s Health Initiative Observational Study. Circulation. 2016;133:2149-2158.
DOI: 10.1161/CIRCULATIONAHA.115.017854

Timpka S, Fraser A, Schyman T, Stuart JJ, Åsvold BO, Mogren I et al. The value of pregnancy complica- tion history for 10-year cardiovascular disease risk prediction in middle-aged women. Eur J Epidemiol. 2018;33:1003-1010.
DOI: 10.1007/s10654-018-0429-1

Brotons C, Camafort M, Castellanos MM, Clarà A, Cortés O et al. Comentario del CEIPVC a las nuevas guías europeas de prevención cardiovascular 2021. Rev Esp Salud Publica 2022;96:1 de marzo. E1-e14.
DOI: 10.55783/rcmf.150207

OMS. “Mejores inversiones” y otras intervenciones recomendadas para la prevención y el control de las enfermedades no transmisibles, 2017. Consultado 11 de Junio 2023. Disponible en: https:// apps.who.int/iris/ bitstream/handle/10665/259351/WHO-NMH-NV1-17.9- spa.pdf.sequence-1

Organización Panamericana de la Salud. El paque- te técnico SAFER. Un mundo libre de los daños relacio- nados con el alcohol. Washington: 2020. Consultado 11 de Junio 2023. Disponible en: https://iris.paho.org/ bitstream/handkle/10665.2/51867/9879275321959_spa. pdf-sequence-5&isAllowed-y

World Health Organization. WHO global air quality guidelines. Particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide. Gi- nebra: WHO; 2021. Consultado 12 Junio 2023. Disponible en: https://apps.who.int/iris/handle/10665/345329

Ministerio de Sanidad. Consumo de alcohol; Infor- mación para decisores politicos. ¿Qué pueden hacer las administraciones públicas? 2021. Consultado 11 de Junio 2023. Disponible en: https://www.sanidad.gob.es/profe- sionales/saludPublica/prevPromoción/Prevencion/alco- hol/docs(ConsumoAlcohol. DecisoresPoliticos.pdf

Floud S, Blangiardo M, Clarck C, de Hoogh K, Ba-

bisch W, Houthuijs D et al. Exposure to aircraft and road traffic noise and association with heart disease and stroke in six European countries: a cross-sectional study. Environ Health 2013;123:89.

Martínez-González MA, Salas-Salvadó J, Estruch R, Corella D, Fitó M, Ros E; PREDIMED INVESTIGATORS. Benefits of the Mediterranean Diet: Insights From the PREDIMED Study. Prog Cardiovasc Dis. 2015;58:50-60.
DOI: 10.1016/j.pcad.2015.04.003

El Convenio Marco de la OMS para el control del Tabaco. Consultado 12 de junio de 2023.Disponible en: https://apps. who.int/iris/bitstream/handle/10665/42813/9243591010. pdf?sequence=1

Powell-Wiley TM, Baumer Y, Baah FO, Baez AS, Farmer N, Mahlobo CT et al. Social Determinants of Car- diovascular Disease. Circ Res. 2022;130:782-799.
DOI: 10.1161/CIRCRESAHA.121.319811

Diez Roux AV. Residential Environments and Car- diovascular Risk. J Urban Health. 2003;80:569-589.
DOI: 10.1093/jurban/jtg065

Institute of Medicine. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. National Academies Press; 2006. Consultado 12 de junio 2023, disponible en: https://nap.nationalacademies.org/ read/11537/chapter/1#ii

Courtney AU, O’Brien EC, Crowley RK, Geragh- ty AA, Brady MB, Kilbane MT, Twomey PJ, McKenna MJ, McAuliffe FM. DASH (Dietary Approaches to Stop Hypertension) dietary pattern and maternal blood pres- sure in pregnancy. J Hum Nutr Diet. 2020;33:686-697.
DOI: 10.1111/jhn.12744

Mijatovic-Vukas J, Capling L, Cheng S, Stamatakis E, Louie J, Cheung N et al. Associations of Diet and Phy- sical Activity with Risk for Gestational Diabetes Melli- tus: A Systematic Review and Meta-Analysis. Nutrients. 2018;10:698.
DOI: 10.3390/nu10060698

Ziaei S, Norrozi M, Faghihzadeh S, Jafarbegloo E. A randomised placebo-controlled trial to determine the effect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin ≥13.2 g/dl. BJOG. 2007;114:684-852.
DOI: 10.1111/j.1471-0528.2007.01325.x

Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Miller NH, Hubbard VS et al. 2013 AHA/ACC Guideline on Li- festyle Management to Reduce Cardiovascular Risk. Cir- culation. 2014;129:2960-2984.

Eshriqui I, Vilela AAF, Rebelo F, Farias DR, Castro MBT, Kac G. Gestational dietary patterns are not asso- ciated with blood pressure changes during pregnancy and early postpartum in a Brazilian prospective cohort. Eur J Nutr. 2016;55:21-32.
DOI: 10.1007/s00394-014-0819-4

Dirección General de Salud Pública. Ministerio de Sanidad y Consumo. Recomendaciones sobre suple- mentación con ácido fólico para la prevención de defec- tos del tubo neural. Inf Ter Sist Nac Salud. 2001;25(66).

Farpour-Lambert NJ, Ells LJ, Martinez de Tejada B, Scott C. Obesity and Weight Gain in Pregnancy and Pos- tpartum: an Evidence Review of Lifestyle Interventions to Inform Maternal and Child Health Policies. Front En- docrinol (Lausanne).2018;9:546
DOI: 10.3389/fendo.2018.00546

Mamun AA, O’Callaghan M, Callaway L, Williams G, Najman J, Lawlor DA. Associations of Gestational Weight Gain With Offspring Body Mass Index and Blood Pressure at 21 Years of Age. Circulation. 2009;119:1720-1727.
DOI: 10.1161/CIRCULATIONAHA.108.813436

Gaillard R, Santos S, Duijts L, Felix JF. Child- hood Health Consequences of Maternal Obesity du- ring Pregnancy: A Narrative Review. Ann Nutr Metab. 2016;69:171-180.
DOI: 10.1159/000453077

Poston L, Caleyachetty R, Cnattingius S, Corvalán C, Uauy R, Herring S et al. Preconceptional and ma- ternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol. 2016;4:1025-1036.
DOI: 10.1016/S2213-8587(16)30217-0

Muktabhant B, Lawrie TA, Lumbiganon P, Laopai- boon M. Diet or exercise, or both, for preventing exces- sive weight gain in pregnancy. Cochrane Database of Systematic Reviews. 2015;2015(6).
DOI: 10.1002/14651858.CD007145.pub3

Ministerio de Sanidad. Estrategia de Promoción de la Salud y Prevención en el SNS. 2013. Consultado el 12 de Junio 2023. Disponible en: https://www.sanidad. gob.es/areas/promocionPrevencion/estrategiaSNS/ home.htm

Evenson KR, Barakat R, Brown WJ, Dargent-Mo- lina P, Haruna M, Mikkelsen EM et al. Guidelines for Physical Activity during Pregnancy: Comparisons From Around the World. Am J Lifestyle Med. 2014;8:102-121.
DOI: 10.1177/1559827613498204

US Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd edition. Department of Health and Human Services; 2018. Con- sultado el 12 de Junio de 2023. Disponible en: https:// health.gov/sites/default/files/2019-09/Physical_Activi- ty_Guidelines_2nd_edition.pdf

ACOG. Committee Opinion No. 549. Obstetrics & Gy- necology. 2013;121:213-217.

Borrell LN, Rodriguez-Alvarez E, Savitz DA, Ba- quero MC. Parental Race/Ethnicity and Adverse Birth Outcomes in New York City: 2000–2010. Am J Public Health. 2016;106:1491-1497.
DOI: 10.2105/AJPH.2016.303242

Appelman Y, van Rijn BB, ten Haaf ME, Boers- ma E, Peters SAE. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis. 2015;241:211-218.
DOI: 10.1016/j.atherosclerosis.2015.01.027

ACOG. Practice Bulletin No. 202: Gestational Hyper- tension and Preeclampsia. Obstetrics & Gynecology. 2019;133:1-1.

Hedderson M, Ehrlich S, Sridhar S, Darbinian J, Moore S, Ferrara A. Racial/Ethnic Disparities in the Pre- valence of Gestational Diabetes Mellitus by BMI. Diabe- tes Care. 2012;35:1492-1498.
DOI: 10.2337/dc11-2267

Shahul S, Tung A, Minhaj M, Nizamuddin J, Wen- ger J, Mahmood E et al. Racial Disparities in Comorbidi- ties, Complications, and Maternal and Fetal Outcomes in Women With Preeclampsia/eclampsia. Hypertens Pregnancy. 2015;34:506-515.
DOI: 10.3109/10641955.2015.1090581

Harville EW, Myers L, Shu T, Wallace ME, Bazza- no LA. Pre-pregnancy cardiovascular risk factors and racial disparities in birth outcomes: the Bogalusa Heart Study. BMC Pregnancy Childbirth. 2018;18:339.
DOI: 10.1186/s12884-018-1959-y

Parker DR, Lu B, Sands-Lincoln M, Kroenke CH, Lee CC, O’Sullivan M et al. Risk of Cardiovascular Disease Among Postmenopausal Women with Prior Preg- nancy Loss: The Women’s Health Initiative. The Annals of Family Medicine. 2014;12:302-309.
DOI: 10.1370/afm.1668

Cirillo PM, Cohn BA. Pregnancy Complications and Cardiovascular Disease Death. Circulation. 2015;132:1234-1242.
DOI: 10.1161/CIRCULATIONAHA.113.003901

Rosenberg L, Adams-Campbell L, Palmer JR. The Black Women’s Health Study: a follow-up study for cau- ses and preventions of illness. J Am Med Womens Assoc (1972). 1995;50:56-58.

Stuebe AM, Rich-Edwards JW. The reset hypothe- sis: lactation and maternal metabolism. Am J Perinatol 2009;26:81-88
DOI: 10.1055/s-0028-1103034

Nguyen B, JIn K, Ding D. Breastfeeding and mater- nal cardiovascular risk factors and outcomes: a siyste- matic review. PLoS One 2017;12:e0187923
DOI: 10.1371/journal.pone.0187923

Gunderson EP, Kim C, Quesenberry CP Jr, Marco- vina S, Walton D, Azevedo Ram Fox G, Elmasian C, Young S, Salvador N et al. Lactation intensity and fas- ting plasma lipids, lipoproteins, non-esterified free fat- ty acids, leptin and adiponectin in postpartum women with recent gestational diabetes mellitus: the SWIFT cohort. Obstet Gynecol 2013;122:111-119

Bartick MC, Stuebe AM, Schwarz EB, Luongo C, Reinhold AG, Foster EM. Cost analysis of maternal di- sease associated with suboptimal breastfeeding. Obstet Gynecol 2013;122:111-119
DOI: 10.1097/AOG.0b013e318297a047

Gunderson EP, Lewis CE, Wei GS, Whitmer RA, Quesenberry CP, Sidney S. Lactation and Changes in Maternal Metabolic Risk Factors. Obstetrics & Gyneco- logy. 2007;109:729-738.
DOI: 10.1097/01.AOG.0000252831.06695.03

Ajmera VH, Terrault NA, VanWagner LB, Sarkar M, Lewis CE, Carr JJ et al. Longer lactation duration is associated with decreased prevalence of non-alcoholic fatty liver disease in women. J Hepatol. 2019;70:126-132.
DOI: 10.1016/j.jhep.2018.09.013

Gunderson EP, Quesenberry CP, Ning X, Jacobs DR, Gross M, Goff DC et al. Lactation Duration and Midlife Athe- rosclerosis. Obstetrics & Gynecology. 2015;126:381-390.
DOI: 10.1097/AOG.0000000000000919

Bonifacino E, Schwartz EB, Jun H, Wessel CB, Corbelli JA. Effect of Lactation on Maternal Hyperten- sion: A Systematic Review. Breastfeeding Medicine. 2018;13:578-588.
DOI: 10.1089/bfm.2018.0108

Qu G, Wang L, Tang X, Wu W, Sun Y. Associa- tion Between Duration of Breastfeeding and Maternal Hypertension: A Systematic Review and Meta-Analysis. Breastfeeding Medicine. 2018;13:318-326.
DOI: 10.1089/bfm.2017.0180

Chetwynd EM, Stuebe AM, Rosenberg L, Troester M, Rowley D, Palmer JR. Cumulative Lactation and On- set of Hypertension in African-American Women. Am J Epidemiol. 2017;186:927-934.
DOI: 10.1093/aje/kwx163

Tschiderer L, Seekircher L, Kunutsor SK, Peters SAE, O’Keeffe LM, Willeit P. Breastfeeding Is Associated with a Reduced Maternal Cardiovascular Risk: Systematic Review and Meta-Analysis Involving Data From 8 Studies and 1 192 700 Parous Women. J Am Heart Assoc. 2022;11(2).
DOI: 10.1161/JAHA.121.022746

Gunderson EP, Lewis CE, Lin Y, Sorel M, Gross M, Sidney S et al. Lactation Duration and Progression to Diabetes in Women Across the Childbearing Years. JAMA Intern Med. 2018;178:328.
DOI: 10.1001/jamainternmed.2017.7978

Peters SAE, Yang L, Guo Y, Chen Y, Bian Z, Du J et al. Breastfeeding and the Risk of Maternal Cardiovas- cular Disease: A Prospective Study of 300 000 Chinese Women. J Am Heart Assoc. 2017;6: e006081

Peters SA, van der Schouw YT, Wood AM, Sweeting MJ, Moons KG, Weiderpass E et al. Parity, breastfeeding and risk of coronary heart disease: A pan-European ca- se-cohort study. Eur J Prev Cardiol. 2016;23:1755-1765.
DOI: 10.1177/2047487316658571

Kirkegaard H, Bliddal M, Støvring H, Rasmussen KM, Gunderson EP, Køber L et al. Breastfeeding and later maternal risk of hypertension and cardiovascular disease-The role of overall and abdominal obesity. Prev Med (Baltim). 2018;114:140-148.
DOI: 10.1016/j.ypmed.2018.06.014

Nguyen B, Gale J, Nassar N, Bauman A, Joshy G, Ding D. Breastfeeding and Cardiovascular Disease Hos- pitalization and Mortality in Parous Women: Evidence From a Large Australian Cohort Study. J Am Heart As- soc. 2019;8:e011056
DOI: 10.1161/JAHA.118.011056

Natland Fagerhaug T, Forsmo S, Jacobsen GW, Mid- thjell K, Andersen LF, Ivar Lund Nilsen T. A prospective population-based cohort study of lactation and cardio- vascular disease mortality: the HUNT study. BMC Public Health. 2013;13:1070.
DOI: 10.1186/1471-2458-13-1070

LoVerde B, Falck A, Donohue P, Hussey-Gardener B. Supports and Barriers to the Provision of Human Milk by Mothers of African American Preterm Infants. Advan- ces in Neonatal Care. 2018;18:179-188.
DOI: 10.1097/ANC.0000000000000477

Burgess A, McDowell W, Ebersold S. Association Between Lactation and Postpartum Blood Pressure in Women with Preeclampsia. MCN: The American Journal of Maternal/Child Nursing. 2019 Mar;44:86-93.
DOI: 10.1097/NMC.0000000000000502

Yu J, Pudwell J, Dayan N, Smith GN. Postpartum Breastfeeding and Cardiovascular Risk Assessment in Women Following Pregnancy Complications. J Womens Health. 2020;29:627-635.
DOI: 10.1089/jwh.2019.7894

Countouris ME, Schwarz EB, Rossiter BC, Althouse AD, Berlacher KL, Jeyabalan A et al. Effects of lactation on postpartum blood pressure among women with ges- tational hypertension and preeclampsia. Am J Obstet Gynecol. 2016;215:241.e1-241.e8.
DOI: 10.1016/j.ajog.2016.02.046

Gunderson EP, Hurston SR, Dewey KG, Faith MS, Charvat-Aguilar N, Khoury VC et al. The study of wo- men, infant feeding and type 2 diabetes after GDM preg- nancy and growth of their offspring (SWIFT Offspring study): prospective design, methodology and baseline characteristics. BMC Pregnancy Childbirth. 2015;15:150.
DOI: 10.1186/s12884-015-0587-z

Aroda VR, Christophi CA, Edelstein SL, Zhang P, Herman WH, Barrett-Connor E et al. The Effect of Li- festyle Intervention and Metformin on Preventing or Delaying Diabetes Among Women with and Without Gestational Diabetes: The Diabetes Prevention Program Outcomes Study 10-Year Follow-Up. J Clin Endocrinol Metab. 2015;100:1646-1653.
DOI: 10.1210/jc.2014-3761

Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X et al. Prevention of Diabetes in Women with a History of Gestational Diabetes: Effects of Metformin and Lifestyle Interventions. J Clin Endocri- nol Metab. 2008;93:4774-4779.
DOI: 10.1210/jc.2008-0772

Syngelaki A, Nicolaides KH, Balani J, Hyer S, Ako- lekar R, Kotecha R et al. Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus. New England Journal of Medicine. 2016;374:434-443.
DOI: 10.1056/NEJMoa1509819

100. Romero R, Erez O, Hüttemann M, Maymon E, Panaitescu B, Conde-Agudelo A et al. Metformin, the aspirin of the 21st century: its role in gestational dia- betes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. Am J Obstet Gynecol. 2017;217:282-302.
DOI: 10.1016/j.ajog.2017.06.003

101. Miller EC, Boehme AK, Chung NT, Wang SS, Lacey JV, Lakshminarayan K et al. Aspirin reduces long-term stroke risk in women with prior hypertensive disorders of pregnancy. Neurology. 2019;92:e305-316.
DOI: 10.1212/WNL.0000000000006815

102. NICE GUIDELINES. Hypertension in Pregnancy: Diagnosis and Management. 2019. Consultado el 11 de Junio de 2023. Disponible en: https://www.nice.org.uk/ guidance/ng133

103. McKinney J, Keyser L, Clinton S, Pagliano C. ACOG Committee Opinion No. 736: Optimizing Postpartum Care. Obstetrics & Gynecology. 2018;132:784-785.
DOI: 10.1097/AOG.0000000000002849

104. Gamble DT, Brikinns B, Myint PK, Bhattacharya

S. Hypertensive Disorders of Pregnancy and Subsequent Cardiovascular Disease: Current National and Inter- national Guidelines and the Need for Future Research. Front Cardiovasc Med. 2019;6:55
DOI: 10.3389/fcvm.2019.00055

105. Khan SS, Cameron NA, Lindley KJ. Pregnancy as an Early Cardiovascular Moment: Peripartum Cardio- vascular Health. Circ Res. 2023;132:1584-1606.
DOI: 10.1161/CIRCRESAHA.123.322001

106. Parikh NI, Gonzalez JM, Anderson CAM, Judd SE, Rexrode KM, Hlatky MA et al; American Heart Associa- tion Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council. Adverse Pregnancy Outcomes and Car- diovascular Disease Risk: Unique Opportunities for Car- diovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association. Circu- lation. 2021;143:e902-e916.
DOI: 10.1161/CIR.0000000000000961